1 Home Page

NEW!  Visit us at ICI 2008, Tel-Aviv, Israel, December 7-9, Booth #18

Please see below a list of MGuard focused sessions at ICI 2008

13:54 Protection against Embolization during PCI-ACS; PIHARTE Trial and MGuard New Data

Dariusz Dudek (Poland)

18:17 The MGuard™ - Net Protective Stent

Ofir Paz (Israel) InspireMD

19:00 Cocktail Reception: MGuardTM, A Unique Solution for Managing Embolic Complications in Acute MI and SVG

 

InspireMD celebrated much success at TCT 2008, Washington DC, USA. October 12-16, Booth #1411

 

BREAKFAST MEETING October 16th - TCT 2008

Meeting Topic: A New Approach to Treating Thrombus - Containing Lesions (SVG, AMI, and ACS)

Meeting Chairman: Martin Leon MD

WHEN: 7:00-8:00am, Thursday October 16

WHERE: Room 143C, Washington Convention Center

 

InspireMD has the pleasure to invite you to the InspireMD Breakfast Meeting at TCT 2008.

This represents a rare opportunity for you to attend a meeting that will discuss the latest clinical data regarding the breakthrough MGuard Technology.

Key world renowned interventional cardiologists will lead the session and you will come away with a deep understanding as to how important the MGuard stent will be as a pioneering technology for the treatment of thrombus containing lesions.

Speakers: Alexandre Abizaid MD, Antonio Colombo MD, Gian-Battista Danzi MD, Dariusz Dudek MD, Eberhard Grube MD, Martin Leon, MD, Chaim Lotan MD, Carlo Di Mario MD, Gregory Pavlides MD.

 ___________________

The “MGuard First in Man Trial - 30 Days’ Results.”  Abstract

This abstract has been accepted for TCT 2008 as a poster. You may be able to view it as abstract number “484." where a full abstract will be available for view at TCT. To date, very promising 30 day and six months results have proven safety and efficacy of the MGuard.

MGuard is not available for sale in the United States


 

 

1

Logon©copyright2008 | InspireMD | All Rights Reserved